DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Baraclude (Entecavir) - Current Clinical Trials

 
 



Baraclude Related Clinical Trials

Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load [Active, not recruiting]

Comparison Between Lamivudine and Entecavir Treatment in Patients [Recruiting]

Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment [Not yet recruiting]

Suboptimal Responders to Adefovir Switching to Entecavir [Completed]

Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude [Recruiting]

Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis B [Active, not recruiting]

Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB) [Recruiting]

Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B [Completed]

Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL [Recruiting]

Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B [Recruiting]

Continue Entecavir Rollover From China [Completed]

Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Patients Who Fail Lamivudine Plus Adefovir [Completed]

Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B [Recruiting]

An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B Infection [Completed]

Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA [Completed]

Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA [Completed]

Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA [Completed]

Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir [Completed]

Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis B [Recruiting]

Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B [Active, not recruiting]

Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma [Recruiting]

Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders [Active, not recruiting]

Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B [Completed]

Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With Entecavir [Recruiting]

Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients [Recruiting]

A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection [Active, not recruiting]

Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis [Enrolling by invitation]

Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALT [Active, not recruiting]

Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B [Completed]

A Study in Japan of the Safety and Antiviral Activity With Chronic Hepatitis B Infection [Completed]

Lactic Acidosis During Entecavir(ETV)Treatment [Terminated]

Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy [Recruiting]

Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B [Completed]

A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection [Completed]

Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection [Active, not recruiting]

Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B [Active, not recruiting]

Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials [Completed]

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus Infection [Active, not recruiting]

Entecavir for Biological Agents Associated HBV Reactivation in Rheumatoid Arthritis Patients [Not yet recruiting]

Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B [Completed]

The Efficacy and Safety of Entecavir Treatment of Patients With Acute on Chronic Hepatitis B Liver Failure [Completed]

Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus [Completed]

Switching to Tenofovir Versus Continuing Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response During Entecavir Therapy: STEEP Study [Recruiting]

Baracle Tab. ® Versus Baraclude Tab.® for Patients With HBeAg Chronic Hepatitis B [Recruiting]

Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis B [Recruiting]

A Phase II Dose Response Study in Japan in Chronic Hepatitis B [Completed]

Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection [Completed]

Entecavir Plus Adefovir in Lamivudine-Resistant Patients [Withdrawn]

Efficacy and Safety Study of Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Who Failed Previous Treatment [Completed]

Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B [Completed]

Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine Therapy [Completed]

Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B [Active, not recruiting]

Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection [Completed]

Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B [Recruiting]

Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection [Active, not recruiting]

A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV Patients [Terminated]

Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease. [Completed]

Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B [Completed]

Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine [Recruiting]

A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection [Terminated]

Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis B [Completed]

Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection [Completed]

Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation [Completed]

Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment [Terminated]

Compare Continuing Lamivudine Plus Adefovir or Adefovir Versus Switching to Entecavir Plus Adefovir in Patients With LAM-resistant Chronic Hepatitis B [Recruiting]

Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program [No longer available]

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B. [Recruiting]

Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection [Completed]

Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver Transplantation [Not yet recruiting]

Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B [Active, not recruiting]

Entecavir for Chronic Hepatitis B [Completed]

Study of ARC-520 in Patients With HBeAg (Hepatitis B e Antigen) Positive Chronic Hepatitis B Virus [Recruiting]

Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy [Active, not recruiting]

Traditional Chinese Medicine Combined With Entecavir to Treat Refractory Liver Fibrosis in Liver Cirrhosis Due to HBV Liver Cirrhosis [Recruiting]

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B. [Completed]

Antiviral Efficacy of Switching to ETV Plus TDF [Active, not recruiting]

Simvastatin for the Treatment of Chronic Hepatitis B [Completed]

Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients [Active, not recruiting]

Optimized Treatment and Regression of HBV-induced Early Cirrhosis [Recruiting]

Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis [Recruiting]

Optimized Treatment and Regression of HBV-induced Liver Fibrosis [Active, not recruiting]

A Study of Combination or Sequential Treatment With PEGASYS (Peginterferon Alfa-2a) and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B [Completed]

Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection [Recruiting]

Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues Therapy [Recruiting]

A Prospective Clinical Trial in Chronic Hepatitis B Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study) [Recruiting]

Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B Infection [Recruiting]

Combination Therapy of Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B Patients [Recruiting]

A Randomized Controlled Trial on the Efficacy of Tenofovir Disoproxil Fumarate (TDF)-Switch Therapy in Chronic Hepatitis B Patients With Incomplete Response to Entecavir [Recruiting]

Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation Therapy [Not yet recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017